MOH
Molina Healthcare, Inc.
Medical - Healthcare Plans
Market Cap$10.28B
5Y Perf.-15.5%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
MOH vs ALHC
Revenue, margins, valuation, and 5-year total return — side by side.
ALHC
Alignment Healthcare, Inc.
Medical - Healthcare Plans
Market Cap$3.71B
5Y Perf.-17.3%
MOH vs ALHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | MOH | ALHC |
|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $10.28B | $3.71B |
| Revenue (TTM) | $45.08B | $4.26B |
| Net Income (TTM) | $188M | $20M |
| Gross Margin | 9.6% | 9.0% |
| Operating Margin | 1.2% | 0.8% |
| Forward P/E | 38.3x | 140.1x |
| Total Debt | $3.95B | $338M |
| Cash & Equiv. | $4.25B | $578M |
MOH vs ALHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
MOH
ALHC
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Molina Healthcare, … (MOH) | 100 | 84.5 | -15.5% |
| Alignment Healthcar… (ALHC) | 100 | 82.7 | -17.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MOH vs ALHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MOH and ALHC are tied at the top with 3 categories each — the right choice depends on your priorities. Alignment Healthcare, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
MOH
Molina Healthcare, Inc.
The Insurance Pick
MOH has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 334.0% 10Y total return vs ALHC's 4.8%
- Lower volatility, beta -0.04, Low D/E 97.1%, current ratio 1.69x
- Lower P/E (38.3x vs 140.1x)
Best for: long-term compounding and sleep-well-at-night
ALHC
Alignment Healthcare, Inc.
The Insurance Pick
ALHC is the clearest fit if your priority is growth exposure and defensive.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- Beta 0.75, current ratio 1.74x
- 46.1% revenue growth vs MOH's 11.7%
Best for: growth exposure and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ALHC | 46.1% revenue growth vs MOH's 11.7% |
| Value | MOH | Lower P/E (38.3x vs 140.1x) |
| Quality / Margins | MOH | Combined ratio 1.0 vs ALHC's 1.0 (lower = better underwriting) |
| Stability / Safety | MOH | Lower D/E ratio (97.1% vs 188.6%) |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | ALHC | +15.4% vs MOH's -37.6% |
| Efficiency (ROA) | ALHC | 1.8% ROA vs MOH's 1.2% |
MOH vs ALHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2023
MOH vs ALHC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMOHLAGGINGALHC
ALHCAlignment Healthcare,…
1leads
MOHMolina Healthcare, In…
1leads
6 Total Categories
CATEGORYLEADERvs ALHCMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ALHC4/6
Valuation MetricsMultiples, price ratios, and targets
MOH4/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
ALHC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MOH is the larger business by revenue, generating $45.1B annually — 10.6x ALHC's $4.3B. Profitability is closely matched — net margins range from 0.5% (ALHC) to 0.4% (MOH). On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | MOHMolina Healthcare… | ALHCAlignment Healthc… |
|---|---|---|
| RevenueTrailing 12 months | $45.1B | $4.3B |
| EBITDAEarnings before interest/tax | $710M | $66M |
| Net IncomeAfter-tax profit | $188M | $20M |
| Free Cash FlowCash after capex | $251M | $237M |
| Gross MarginGross profit ÷ Revenue | +9.6% | +9.0% |
| Operating MarginEBIT ÷ Revenue | +1.2% | +0.8% |
| Net MarginNet income ÷ Revenue | +0.4% | +0.5% |
| FCF MarginFCF ÷ Revenue | +0.6% | +5.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.1% | +33.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -95.0% | +2.1% |
ALHC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
MOH leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, MOH's 10.2x EV/EBITDA is more attractive than ALHC's 76.6x.
| Metric | MOHMolina Healthcare… | ALHCAlignment Healthc… |
|---|---|---|
| Market CapShares × price | $10.3B | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $10.0B | $3.5B |
| Trailing P/EPrice ÷ TTM EPS | 22.13x | -4902.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 38.29x | 140.08x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 10.23x | 76.63x |
| Price / SalesMarket cap ÷ Revenue | 0.23x | 0.94x |
| Price / BookPrice ÷ Book value/share | 2.46x | 20.04x |
| Price / FCFMarket cap ÷ FCF | — | 32.75x |
MOH leads this category, winning 4 of 5 comparable metrics.
Profitability & Efficiency
Evenly matched — MOH and ALHC each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
ALHC delivers a 11.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $4 for MOH. MOH carries lower financial leverage with a 0.97x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x. On the Piotroski fundamental quality scale (0–9), ALHC scores 6/9 vs MOH's 4/9, reflecting solid financial health.
| Metric | MOHMolina Healthcare… | ALHCAlignment Healthc… |
|---|---|---|
| ROE (TTM)Return on equity | +4.4% | +11.5% |
| ROA (TTM)Return on assets | +1.2% | +1.8% |
| ROICReturn on invested capital | +17.4% | — |
| ROCEReturn on capital employed | +9.8% | +2.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.97x | 1.89x |
| Net DebtTotal debt minus cash | -$298M | -$240M |
| Cash & Equiv.Liquid assets | $4.2B | $578M |
| Total DebtShort + long-term debt | $4.0B | $338M |
| Interest CoverageEBIT ÷ Interest expense | 2.12x | 1.27x |
Evenly matched — MOH and ALHC each lead in 4 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — MOH and ALHC each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MOH five years ago would be worth $7,490 today (with dividends reinvested), compared to $7,216 for ALHC. Over the past 12 months, ALHC leads with a +15.4% total return vs MOH's -37.6%. The 3-year compound annual growth rate (CAGR) favors ALHC at 35.9% vs MOH's -12.5% — a key indicator of consistent wealth creation.
| Metric | MOHMolina Healthcare… | ALHCAlignment Healthc… |
|---|---|---|
| YTD ReturnYear-to-date | +10.6% | -10.3% |
| 1-Year ReturnPast 12 months | -37.6% | +15.4% |
| 3-Year ReturnCumulative with dividends | -33.1% | +150.9% |
| 5-Year ReturnCumulative with dividends | -25.1% | -27.8% |
| 10-Year ReturnCumulative with dividends | +334.0% | +4.8% |
| CAGR (3Y)Annualised 3-year return | -12.5% | +35.9% |
Evenly matched — MOH and ALHC each lead in 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — MOH and ALHC each lead in 1 of 2 comparable metrics.
Risk & Volatility
MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than ALHC's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALHC currently trades 76.0% from its 52-week high vs MOH's 59.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MOHMolina Healthcare… | ALHCAlignment Healthc… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.04x | 0.75x |
| 52-Week HighHighest price in past year | $333.00 | $23.87 |
| 52-Week LowLowest price in past year | $121.06 | $11.63 |
| % of 52W HighCurrent price vs 52-week peak | +59.3% | +76.0% |
| RSI (14)Momentum oscillator 0–100 | 74.7 | 38.0 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 3.6M |
Evenly matched — MOH and ALHC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates MOH as "Buy" and ALHC as "Buy". Consensus price targets imply 36.9% upside for ALHC (target: $25) vs -15.9% for MOH (target: $166).
| Metric | MOHMolina Healthcare… | ALHCAlignment Healthc… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $166.09 | $24.83 |
| # AnalystsCovering analysts | 38 | 16 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +9.7% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
ALHC leads in 1 of 6 categories (Income & Cash Flow). MOH leads in 1 (Valuation Metrics). 3 tied.
Best OverallMolina Healthcare, Inc. (MOH)Leads 1 of 6 categories
Loading custom metrics...
MOH vs ALHC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MOH or ALHC a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 11. 7% for Molina Healthcare, Inc. (MOH). Molina Healthcare, Inc. (MOH) offers the better valuation at 22. 1x trailing P/E (38. 3x forward), making it the more compelling value choice. Analysts rate Molina Healthcare, Inc. (MOH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MOH or ALHC?
On forward P/E, Molina Healthcare, Inc.
is actually cheaper at 38. 3x.
03Which is the better long-term investment — MOH or ALHC?
Over the past 5 years, Molina Healthcare, Inc.
(MOH) delivered a total return of -25. 1%, compared to -27. 8% for Alignment Healthcare, Inc. (ALHC). Over 10 years, the gap is even starker: MOH returned +334. 0% versus ALHC's +4. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MOH or ALHC?
By beta (market sensitivity over 5 years), Molina Healthcare, Inc.
(MOH) is the lower-risk stock at -0. 04β versus Alignment Healthcare, Inc. 's 0. 75β — meaning ALHC is approximately -2145% more volatile than MOH relative to the S&P 500. On balance sheet safety, Molina Healthcare, Inc. (MOH) carries a lower debt/equity ratio of 97% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MOH or ALHC?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus 11. 7% for Molina Healthcare, Inc. (MOH). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -56. 3% for Molina Healthcare, Inc.. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MOH or ALHC?
Molina Healthcare, Inc.
(MOH) is the more profitable company, earning 1. 0% net margin versus -0. 0% for Alignment Healthcare, Inc. — meaning it keeps 1. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MOH leads at 1. 7% versus 0. 4% for ALHC. At the gross margin level — before operating expenses — ALHC leads at 12. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MOH or ALHC more undervalued right now?
On forward earnings alone, Molina Healthcare, Inc.
(MOH) trades at 38. 3x forward P/E versus 140. 1x for Alignment Healthcare, Inc. — 101. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 36. 9% to $24. 83.
08Which pays a better dividend — MOH or ALHC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is MOH or ALHC better for a retirement portfolio?
For long-horizon retirement investors, Molina Healthcare, Inc.
(MOH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), +334. 0% 10Y return). Both have compounded well over 10 years (MOH: +334. 0%, ALHC: +4. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MOH and ALHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MOH is a mid-cap quality compounder stock; ALHC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(MOH: -3.1% · ALHC: 33.3%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.